Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2

The development of effective antiviral drugs against SARS-CoV-2 is urgently needed and a global health priority. In light of the initial data regarding the repurposing of hydroxychloroquine (HCQ) to tackle this coronavirus, herein we present a quantitative synthesis and spectroscopic and thermal cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Faísca, Francisco, Correia, Vanessa, Petrovski, Željko, Branco, Luís C., Rebelo-de-Andrade, Helena, Santos, Miguel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031298/
https://www.ncbi.nlm.nih.gov/pubmed/35456711
http://dx.doi.org/10.3390/pharmaceutics14040877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031298/
https://www.ncbi.nlm.nih.gov/pubmed/35456711
http://dx.doi.org/10.3390/pharmaceutics14040877

Ejemplares similares